✦ LIBER ✦

Accounting for geographical inequalities in the assessment of equity in health care: a benefit incidence analysis

✍ Scribed by Anselmi, Laura; Fernandes, Quinhas F; Hanson, Kara; Lagarde, Mylene

Book ID: 122017053
Publisher: The Lancet
Year: 2013
Tongue: English
Weight: 55 KB
Volume: 381
Category: Article
ISSN: 0140-6736
DOI: 10.1016/S0140-6736(13)61263-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Accounting for the dead in the longitudi

Accounting for the dead in the longitudinal analysis of income-related health inequalities

✍ Dennis Petrie; Paul Allanson; Ulf-G. Gerdtham 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 377 KB

PMC17 ACCOUNTING FOR INITIAL HEALTH STAT

PMC17 ACCOUNTING FOR INITIAL HEALTH STATUS IN MEASURING THE BENEFITS OF HEALTH CARE TECHNOLOGIES

✍ MJ Taylor 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB

Assessing equity in health care through

Assessing equity in health care through the national health insurance schemes of Nigeria and Ghana: a review-based comparative analysis

✍ Isaac AO Odeyemi, John Nixon 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 342 KB

The quest for equity in Latin America: a

The quest for equity in Latin America: a comparative analysis of the health care reforms in Brazil and Colombia

✍ Roberto JF Esteves 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 519 KB

Are the poor differentially benefiting f

Are the poor differentially benefiting from provision of priority public health services? A benefit incidence analysis in Nigeria

✍ Obinna Onwujekwe, Kara Hanson, Benjamin Uzochukwu 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 222 KB

Commercialisation, inequality and the li

Commercialisation, inequality and the limits to transition in health care: a Polanyian framework for policy analysis

✍ Maureen Mackintosh 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 248 KB

The effects of commercialised health care in embedding, exacerbating and legitimating social and economic inequality are at the root of widespread and recurrent resistance to commercialisation in health. In low income developing countries suffering generalised poverty, and notably in Sub-Saharan Afr